<DOC>
	<DOCNO>NCT00372255</DOCNO>
	<brief_summary>The study evaluate immune response tolerability influenza vaccine administer child age 6-13 year old .</brief_summary>
	<brief_title>Study Immunogenicity Tolerability Influsplit SSW® 2005/2006 Children Aged 6 - 13 Years</brief_title>
	<detailed_description />
	<criteria>Healthy child child increase health risk due underlie chronic disease—such chronic airway disease ( include asthma ) , chronic cardiovascular , hepatic renal disease well diabetes metabolic diseases—aged 6 13 year . All subject must receive prior influenza vaccination . All subject must prior influenza disease . Use study unlicensed medications/ vaccine study vaccine within 30 day vaccination and/or study period . Acute illness start study . Acute , clinically significant pulmonary , cardiovascular abnormality abnormalities hepatic renal function . Known allergic reaction might cause ingredient vaccine . Girls postmenarche : pregnancy positive pregnancytest Multiple sclerosis congenital acquire immunodeficiency .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>